CCL2 and prostate cancer: Human PC3 prostate cancer cells, when co-cultured with HUVECs, in which PEAR1 or CCL2 was knocked down showed increased proliferation and decreased dormancy compared to PC3 cells cultured together with control HUVECs (Suppl.